Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

[Can therapeutic strategy favor the passage to chronicity in metastatic non-small-cell lung cancer?].

Westeel V.

Rev Pneumol Clin. 2006 Feb;62 Spec no 1:1S14-5. French. No abstract available.

PMID:
16719149
2.

Longitudinal perceptions of prognosis and goals of therapy in patients with metastatic non-small-cell lung cancer: results of a randomized study of early palliative care.

Temel JS, Greer JA, Admane S, Gallagher ER, Jackson VA, Lynch TJ, Lennes IT, Dahlin CM, Pirl WF.

J Clin Oncol. 2011 Jun 10;29(17):2319-26. doi: 10.1200/JCO.2010.32.4459. Epub 2011 May 9.

PMID:
21555700
3.

Invited commentary.

Fieguth HG.

Ann Thorac Surg. 2005 Sep;80(3):1026-7. No abstract available.

PMID:
16122478
4.

Lung cancer adjuvant therapy.

Horn L, Sandler A.

Cancer J. 2007 May-Jun;13(3):210-6. Review.

PMID:
17620772
5.

Clinical trials referral resource. Clinical trials in lung cancer.

Feigal EG, Cheson BD, Nelson AP.

Oncology (Williston Park). 1997 Nov;11(11):1686, 1688, 1691, 1694. No abstract available.

PMID:
9394366
6.

Non-small cell lung cancer: new hope for a chronic illness.

Tyson LB.

Oncol Nurs Forum. 2007 Sep;34(5):963-70. Review. No abstract available.

PMID:
17878125
7.

Consensus on medical treatment of non-small cell lung cancer.

Central European Cooperative Oncology Group(CECOG); Advisory Committee on Collaboration with Industry in Medical Education of the European School of Oncolofy (ESO); Vienna Medical Association.

Lung Cancer. 2002 Dec;38 Suppl 3:S3-7. Review. No abstract available.

PMID:
12468137
8.

[What is to be expected from population studies in relation to clinical trials?].

Quoix E.

Rev Pneumol Clin. 2006 Feb;62 Spec no 1:1S19-21. French. No abstract available.

PMID:
16719151
9.

Systemic and combined modality therapy for lung cancer.

Ettinger DS.

Md Med J. 1990 Apr;39(4):315-6. No abstract available.

PMID:
2159100
10.

What is the optimal treatment of stage IIIA-N2 non-small-cell lung cancer after EORTC 08941?

Van Meerbeeck JP, De Pauw R, Tournoy K.

Expert Rev Anticancer Ther. 2008 Feb;8(2):199-206. doi: 10.1586/14737140.8.2.199. Review.

PMID:
18279061
11.

Mortality associated with pneumonectomy after induction chemoradiation versus chemotherapy alone in stage IIIA-N2 non-small cell lung cancer.

Van Schil PE.

J Thorac Cardiovasc Surg. 2008 Mar;135(3):718; author reply 718-9. doi: 10.1016/j.jtcvs.2007.10.052. No abstract available.

12.
13.

Adjuvant chemotherapy for early-stage non-small cell lung cancer: the past, the present and the future.

Potti A, Ganti AK.

Expert Opin Biol Ther. 2006 Jul;6(7):709-16. Review.

PMID:
16805710
14.

[A comparison of efficacy of different modalities of treatment for locally-advanced and metastatic non-small lung cancer].

Arsen'ev AI, Barchuk AS, Kanaev SV, Shulepov AV, Morozova IuA, Barchuk AA, Tarkov SA, Vedenin IaO.

Vopr Onkol. 2008;54(3):281-6. Russian.

PMID:
18652231
15.

Long term disease-free survival resulting from combined modality management of patients presenting with oligometastatic, non-small cell lung carcinoma (NSCLC).

Khan AJ, Mehta PS, Zusag TW, Bonomi PD, Penfield Faber L, Shott S, Abrams RA.

Radiother Oncol. 2006 Nov;81(2):163-7. Epub 2006 Oct 16.

PMID:
17050016
16.

Trimodal therapy for histologically proven N2/3 non-small cell lung cancer: mid-term results and indicators for survival.

Steger V, Walles T, Kosan B, Walker T, Kyriss T, Veit S, Dippon J, Friedel G.

Ann Thorac Surg. 2009 Jun;87(6):1676-83. doi: 10.1016/j.athoracsur.2009.03.068.

PMID:
19463576
17.

Stage IIIA-N2 NSCLC: a review of its treatment approaches and future developments.

van Meerbeeck JP, Surmont VF.

Lung Cancer. 2009 Sep;65(3):257-67. doi: 10.1016/j.lungcan.2009.02.007. Epub 2009 Mar 13. Review.

PMID:
19285751
18.

Video-assisted thoracic surgery pulmonary resection for lung cancer in patients with poor lung function.

Garzon JC, Ng CS, Sihoe AD, Manlulu AV, Wong RH, Lee TW, Yim AP.

Ann Thorac Surg. 2006 Jun;81(6):1996-2003.

PMID:
16731119
19.

Lung cancer in North Carolina.

Rimer BK, Herman D, Crawford J, Blackwell S.

N C Med J. 1993 Jul;54(7):334-40. No abstract available.

PMID:
8394512
20.

Survival prognostication in non-small cell lung cancer.

Zell JA, Ignatius Ou SH.

J Thorac Oncol. 2009 Jul;4(7):785-6. doi: 10.1097/JTO.0b013e3181a99fa2. No abstract available.

Supplemental Content

Support Center